{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:08:48Z","timestamp":1764079728927,"version":"3.33.0"},"reference-count":43,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.2967\/jnumed.121.262447","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T17:53:13Z","timestamp":1631209993000},"page":"882-889","source":"Crossref","is-referenced-by-count":2,"title":["Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After<sup>90<\/sup>Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity"],"prefix":"10.2967","volume":"63","author":[{"given":"Matthew M.","family":"Cousins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa P.","family":"Devasia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Maurino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Mikell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi K.","family":"Kaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore. S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle C.","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuni K.","family":"Dewaraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"2025012107351108000_63.6.882.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29691"},{"key":"2025012107351108000_63.6.882.2","unstructured":"TheraSphere\u00ae Yttrium-90 Glass Microspheres. Package insert. BTG; undated."},{"key":"2025012107351108000_63.6.882.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04340-5"},{"key":"2025012107351108000_63.6.882.4","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.075861"},{"key":"2025012107351108000_63.6.882.5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"2025012107351108000_63.6.882.6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fonc.2014.00210","article-title":"Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective","volume":"4","author":"Cremonesi","year":"2014","journal-title":"Front Oncol."},{"key":"2025012107351108000_63.6.882.7","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00259-015-3068-8","article-title":"Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology","volume":"42","author":"Chiesa","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025012107351108000_63.6.882.8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00198"},{"key":"2025012107351108000_63.6.882.9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3390\/cancers12061557","article-title":"Personalised dosimetry in radioembolisation for HCC: impact on clinical outcome and on trial design","volume":"12","author":"Garin","year":"2020","journal-title":"Cancers (Basel)."},{"key":"2025012107351108000_63.6.882.10","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1007\/s00259-020-04845-4","article-title":"Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship","volume":"47","author":"Chiesa","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025012107351108000_63.6.882.11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijrobp.2018.05.062","article-title":"Hepatocellular carcinoma tumor dose response after 90Y-radioembolization with glass microspheres using 90Y-SPECT\/CT-based voxel dosimetry","volume":"102","author":"Kappadath","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2025012107351108000_63.6.882.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.226472"},{"key":"2025012107351108000_63.6.882.13","doi-asserted-by":"crossref","first-page":"100950","DOI":"10.1016\/j.tranon.2020.100950","article-title":"TNFR1 and the TNF\u03b1 axis as a targetable mediator of liver injury from stereotactic body radiation therapy","volume":"14","author":"Cousins","year":"2021","journal-title":"Transl Oncol."},{"key":"2025012107351108000_63.6.882.14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.tranon.2019.04.003","article-title":"Serum levels of hepatocyte growth factor and CD40 ligand predict radiation-induced liver injury","volume":"12","author":"Cuneo","year":"2019","journal-title":"Transl Oncol."},{"key":"2025012107351108000_63.6.882.15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41698-018-0065-y","article-title":"Pretreatment plasma HGF as potential biomarker for susceptibility to radiation-induced liver dysfunction after radiotherapy","volume":"2","author":"Hong","year":"2018","journal-title":"NPJ Precis Oncol."},{"key":"2025012107351108000_63.6.882.16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2020.09.001","article-title":"Pretreatment neutrophil-to-lymphocyte ratio predicts survival and liver toxicity in patients with hepatocellular carcinoma treated with stereotactic ablative radiation therapy","volume":"109","author":"Lo","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2025012107351108000_63.6.882.17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00270-017-1622-4","article-title":"Cytokines and 90Y-radioembolization: relation to liver function and overall survival","volume":"40","author":"Seidensticker","year":"2017","journal-title":"Cardiovasc Intervent Radiol."},{"key":"2025012107351108000_63.6.882.18","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12592"},{"key":"2025012107351108000_63.6.882.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)01420-6"},{"key":"2025012107351108000_63.6.882.20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2017.12.290","article-title":"Radiation dose\u2010volume effects for liver SBRT","volume":"110","author":"Miften","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2025012107351108000_63.6.882.21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.hpb.2015.07.002","article-title":"A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90","volume":"18","author":"Teo","year":"2016","journal-title":"HPB (Oxford)."},{"key":"2025012107351108000_63.6.882.22","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00418-K"},{"key":"2025012107351108000_63.6.882.23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.9151"},{"key":"2025012107351108000_63.6.882.24","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830271119"},{"key":"2025012107351108000_63.6.882.25","doi-asserted-by":"publisher","DOI":"10.1007\/s40139-015-0093-z"},{"key":"2025012107351108000_63.6.882.26","doi-asserted-by":"crossref","unstructured":"Holbrook J Lara-Reyna S Jarosz-Griffiths H McDermott M . Tumour necrosis factor signalling in health and disease. F1000Res. 2019;8:F1000.","DOI":"10.12688\/f1000research.17023.1"},{"key":"2025012107351108000_63.6.882.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI694"},{"key":"2025012107351108000_63.6.882.28","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.4049\/jimmunol.158.8.3869","article-title":"Constitutive shedding of both p55 and p75 murine TNF receptors in\u00a0vivo","volume":"158","author":"Pinckard","year":"1997","journal-title":"J Immunol."},{"key":"2025012107351108000_63.6.882.29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3748\/wjg.v8.i6.1129","article-title":"Shedding of TNFR1 in regenerative liver can be induced with TNF alpha and PMA","volume":"8","author":"Xia","year":"2002","journal-title":"World J Gastroenterol."},{"key":"2025012107351108000_63.6.882.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01191.x"},{"key":"2025012107351108000_63.6.882.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2004.07.001"},{"key":"2025012107351108000_63.6.882.32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0360"},{"key":"2025012107351108000_63.6.882.33","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3205"},{"key":"2025012107351108000_63.6.882.34","first-page":"27","article-title":"Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions","volume":"3","author":"Matsumoto","year":"1992","journal-title":"Crit Rev Oncog."},{"key":"2025012107351108000_63.6.882.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.12.170"},{"key":"2025012107351108000_63.6.882.36","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(92)90019-6"},{"key":"2025012107351108000_63.6.882.37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.068"},{"key":"2025012107351108000_63.6.882.38","doi-asserted-by":"crossref","first-page":"e0173506","DOI":"10.1371\/journal.pone.0173506","article-title":"Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease","volume":"12","author":"Krawczyk","year":"2017","journal-title":"PLoS One."},{"key":"2025012107351108000_63.6.882.39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40264-018-0780-x","article-title":"Safety and tolerability of c-MET inhibitors in cancer","volume":"42","author":"Puccini","year":"2019","journal-title":"Drug Saf."},{"key":"2025012107351108000_63.6.882.40","unstructured":"Chiang GT Glaser RL . Clinical review: GP2015 (proposed biosimilar to US-licensed Enbrel). Food and Drug Administration website. https:\/\/www.fda.gov\/media\/105952\/download. Published November 5, 2015. Accessed February 22, 2022."},{"key":"2025012107351108000_63.6.882.41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1088\/1361-6560\/aa5088","article-title":"Effects of image noise, respiratory motion, and motion compensation on 3D activity quantification in count-limited PET images","volume":"62","author":"Siman","year":"2017","journal-title":"Phys Med Biol."},{"key":"2025012107351108000_63.6.882.42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00259-019-04588-x","article-title":"The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure","volume":"47","author":"Pasciak","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025012107351108000_63.6.882.43","doi-asserted-by":"crossref","first-page":"245010","DOI":"10.1088\/1361-6560\/aaf205","article-title":"90Y TOF-PET based EUD reunifies patient survival prediction in resin and glass microspheres radioembolization of HCC tumours","volume":"63","author":"d\u2019Abadie","year":"2018","journal-title":"Phys Med Biol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.121.262447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T16:04:37Z","timestamp":1737475477000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.121.262447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.2967\/jnumed.121.262447"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.121.262447","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"type":"print","value":"0161-5505"},{"type":"electronic","value":"2159-662X"}],"subject":[],"published":{"date-parts":[[2021,9,9]]}}}